BPB Reports
Online ISSN : 2434-432X
Report
Relationship Between Affinity of Kn2-7 to CpG DNA and the Ability of Kn2-7 to Enhance Cellular Uptake of CpG DNA by RAW264.7 Cells
Saeka NishiharaMayu WakitaKiyoshi Kawasaki
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML

2021 Volume 4 Issue 2 Pages 55-58

Details
Abstract

Some α-helical antimicrobial peptides enhance the activation of immune cells induced by the recognition of DNA containing unmethylated cytosine-guanine motifs (CpG DNA). We recently found that an α-helical antimicrobial peptide FIKRIARLLRKIF, known as Kn2-7, increased CpG DNA-dependent responses in mouse macrophage-like RAW264.7 cells, and we also found that enhanced cellular uptake of CpG DNA by Kn2-7 was necessary but insufficient to augment CpG DNA-dependent responses. In this study, we clarified the relationship between the affinity of Kn2-7 to CpG DNA and the ability of Kn2-7 to enhance cellular uptake of DNA. Electrophoretic mobility analysis on a polyacrylamide gel revealed that Kn2-7 binds to CpG DNA more effectively than Kn2-7RA in which arginine residues of Kn2-7 were substituted with alanine residues, and also found that Kn2-7 binds to CpG DNA less effectively than Kn2-7KR in which lysine residues of Kn2-7 were substituted with arginine residues. The DNA-binding abilities of Kn2-7, Kn2-7RA, and Kn2-7KR correlated well with their abilities to enhance the cellular uptake of CpG DNA. In contrast, Kn2-7LA in which leucine residues of Kn2-7 were substituted with alanine residues exhibited a similar DNA-binding ability to Kn2-7, but it did not enhance cellular uptake of CpG DNA. Our results indicate that affinity to DNA is necessary for the ability of Kn2-7 to enhance cellular uptake of CpG DNA, but hydrophobicity of Kn2-7 is also necessary for the enhancement of cellular uptake.

Content from these authors
© 2021 The Pharmaceutical Society of Japan

BPB Reports applies the Creative Commons Attribution (CCBY) license to works we published. The license was developed to facilitate open access - namely, free immediate access to, and unrestricted reuse of, original works to all types. Under this license, authors agree to make articles legally available for reuse, without permissions of fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited.
https://creativecommons.org/licenses/by/4.0/
Next article
feedback
Top